Roche to present new pivotal data at ASH 2021 from broad and comprehensive portfolio, challenging treatment standards for people with blood disorders

Phase III POLARIX trial showed Polivy plus R-CHP was the first treatment in two decades to significantly improve outcomes in newly diagnosed diffuse large B-cell lymphoma (DLBCL) versus the standard of care1 Pivotal data on mosunetuzumab, a potential first-in-class CD20xCD3 T-cell engaging bispecific antibody, showed high response rates in relapsed or refractory follicular lymphoma (FL)2... Read more

Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IK

November 22, 2021 For Immediate Release Daicel Chiral Technologies Announces the Launch of CHIRALPAK® IK West Chester, PA (November 22, 2021) —Daicel Chiral Technologies today announced the introduction of CHIRALPAK® IK, adding new selectivity capabilities to the Daicel portfolio. This new immobilized selector builds on the success of CHIRALPAK IG, one of the most effective chiral chromatography phases... Read more

PerkinElmer Launches Cloud Based Solution to Enable Remote Lab Management

The PKeye Workflow Monitor offers 24/7 monitoring capabilities to ensure high productivity and throughput WALTHAM, Mass. – November 22, 2021 – PerkinElmer, Inc., a global leader committed to innovating for a healthier world, today announced the launch of its PKeye™ Workflow Monitor, a cloud-based platform enabling laboratory personnel to remotely manage and monitor their PerkinElmer... Read more

Towards the Battery of the Future

Battery technology may be the keystone of the energy transition, facilitating the decarbonization of the transportation sector while providing a critical backstop for intermittent solar and wind power generation. Both the energy and automobile industries are currently involved in extensive battery research. The trend for electromobility adds extra weight to the subject. Research labs, universities... Read more

PacBio Grants Equity Incentive Award to New Employee

MENLO PARK, Calif., Nov. 19, 2021 (GLOBE NEWSWIRE) — PacBio (NASDAQ: PACB), a leading provider of high-quality, highly accurate sequencing platforms, today announced that the Compensation Committee of the Company’s Board of Directors granted non-qualified stock options covering an aggregate of 80,000 shares of PacBio common stock, and restricted stock units (“RSUs”) covering 40,000 shares... Read more

European Commission approves Roche’s Gavreto (pralsetinib) for the treatment of adults with RET fusion-positive advanced non-small cell lung cancer

Gavreto is the first and only precision medicine approved in the EU for first-line treatment of people with RET fusion-positive advanced NSCLC Conditional approval is based on results from the phase I/II ARROW study, in which Gavreto led to durable responses in people with RET fusion-positive advanced NSCLC Basel, 19 November 2021 – Roche (SIX:... Read more

Bruker Announces Acquisition of MOLECUBES NV

Expands Nuclear Molecular Imaging Portfolio with Modular Benchtop CUBES™ PET, SPECT and CT Preclinical Imaging Systems GHENT, Belgium–(BUSINESS WIRE)– Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of MOLECUBES NV, a dynamic innovator in benchtop preclinical nuclear molecular imaging (NMI) systems. This acquisition strengthens Bruker’s position as a leading NMI solutions provider in preclinical and... Read more

Xylem Announces New Investor Relations Leadership

RYE BROOK, N.Y.–(BUSINESS WIRE)–Nov. 18, 2021– Xylem Inc. (NYSE: XYL), a leading global water technology company, today announced a change in the leadership of its Investor Relations team. Matthew Latino, currently Vice President, Investor Relations, is appointed Vice President, Finance, of Xylem’s Applied Water Systems (AWS) business and the Americas Commercial Team (ACT), effective January... Read more